Earnings Reportpositive
Earnings Report
Other upcoming events for NBIX
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-106584
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-106584
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-106584
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.